Harm Reduction Group Starting in Sudbury Ont.

So it rained yet again today cooling things down yet again!we have yet to hit over 30c this summer!Blue berries R few & far between as they have been raked by pro pickers,sad as this could have added a grand to my bank account that never seems to get ahead!I upgraded my cable so now i get to watch alot more BS!I like the documentarys as they teach U something.Anything that expands my horizens & broadens my knowledge base is a good thing.There's a faciliator prt 2 coming up in Nov.So thats something to look forward too!Harm Reduction group is having its first meeting at the action Centre Aug 14 at 6:30 for those that R practicing this or would like more info...call 705 585 1389 & ask for james....thats in the city of sudbury eh folks!Nways there is also a training thing on harm reduction coming up in Toronto soon & more details will be available at this meeting.K folks-been a long-but good,day .Peace,love & happiness to you all!!!!

Kadr Facing Justice?Torture & Interrogation by US Personal

Now i am not sure how other Canadian's feel about this whole mess,but i ,for 1,think this guy has suffered enough already at the hands of US authorities.Being only a child captured during combat-1 would think that the GEVEVA CONVENTIONS WOULD APPLY!IT'S OBVIOUS IT DOES NOT-How sad for America to be making enemy's where it has friends,& friends where it has enemys.But this has always been US policy,betting on all sides is alot safer!!!This whole middle east thing is a mess!I would like to see canada get TF out of afganistan as we R not invaders!!!We R SUPPOSED to B PEACEKEEPERS!!!WE SHOULD BE DOING THIS ONLY!The Harper GOV should be doing all it can for this young man has spent the last 6 yrs in jail,while the US has NO evidence to convict this guy on.Nadda!NO SOLID FORENSIC SCIENCE TO BACK UP THE PROSECUTION'S CLAIMS!!!THIS IS JUSTICE?IF IT IS,THEN GOD HELP US ALL EH!Because this is only the beginning of the END!Its ONLY going to get worse,slowly at first.It will pick up speed,& soon this whole planet will explode!Gas prices R only going up & up.How far up before we wake up?We MUST CHANGE ENGINE POWER FROM GAS TO SOLAR-WIND-NUCLEAR-HYDROGEN-& WE MUST START BUILDING UNDERGROUND!!ONLY SAFE PLACE IN A WINDSTORM IS BELOW THE EARTH ITSELF!so Y not build below ?We have alreadt started with subways-just expand it on a vast scale-& build high speed tunnels that connect each city.Not communications would have to be by wire,or cable,highspeed ya but still.How will living underground effect the human race?Eyes would get bigger,pupils would enlarge to let in more light-or to see more in less light.Gee did we go offtrack or wat>?Well i could never concentrate on just 1 thing at a time,ADD?loljk!Too much weed intake!!!But i really do hope this KADR gets a chance to have his say in court-at a fair trial-only in CANADA EGH!HE IS CANADIAN!!!SHAME ON HARPER HANGIN HIM OUT TO DRY!LIKE THE REST OF CANADA MR HARPER IS SELLING OUT TO THE USA CAUSE THEY GOT THE BIGGEST STICK!!!Y NOT CUT US ALL A CHECK FOR A MIL & TAKE IT OVER LEAGAL LIKE?WELL I AM STILL SINGLE & STILL SEARCHING 4 LOVE!BEING POZ CAN SUCK 4 THAT REASON ALONE!ITS HARD TRYING TO FIND A DATE/GF,FRIEND WEN U R POZ-NWAYS HAVE A GOOD DAY FOLKS!PEACE N LOVE NOT WARS N WALLS EH!!

LEADERSHIP TRAINING FACING FUNDING CUTS!!!!

GENE THERAPIESHGTV43 by Enzo Biochem is an “antisense” therapy designed to produce CD4 cells (T-cells) that resist infection by HIV. It is in Phase I trials.
M87o by EUFETS AG is a gene therapy that makes T-cells resist infection by HIV. It is being studied in a Phase I trial.
Modified CD4 and CD8 cells by Cell Genesys are genetically modified to block attachment by HIV.
RRz2 by Johnson & Johnson is a ribozyme that attacks HIV’s tat gene. It is in Phase II trials.
VRX496 by VIRxSYS is a genetic factor that infects T-cells and attacks HIV’s genetic code. It is in a Phase I study.
--------------------------------------------------------------------------------
IMMUNE STIMULATORSWe can think of most antiviral drugs as "offense", attacking the virus to slow down its multiplication. Another approach to treating HIV infection is "defense", strengthening the immune response of people who are infected. This Fact Sheet describes new immune stimulators being developed. --------------------------------------------------------------------------------
CYTOKINESSome of these treatments use the body's own chemical messengers (cytokines) to increase the immune system's response to HIV. Different cytokines carry different messages to cells of the immune system. Some cytokines tell a cell to start multiplying; others can tell a cell to self-destruct.
Interferon exists in the body in several forms. Hemispherx Biopharma is testing Ampligen, a form of interferon, in Phase II and Phase III trials. It is supposed to activate some of the cell's own defenses against viruses.
The best-known cytokine is interleukin-2 (IL-2, Aldesleukin, Proleukin) by Chiron Corporation. See Fact Sheet 472 for more information on Interleukin-2. It is currently in Phase III trials. Bayer Corporation is studying Bay 50-4798, a modified recombinant form of IL-2, in Phase II trials.
Interleukin-7 is being developed by Cytheris Corp as a general immune system booster. It is in Phase I/II trials.
Multikine by Cel-Sci Corporation, is a mixture of several different cytokines. It is in Phase I human trials.
Tumor necrosis factor alpha (TNF-á) is an immune system protein that is over-produced in immune disorders. Advanced Biotherapy is studying a TNF-á blocker in a Phase I trial.-------------------------------------------------------------------------------- VACCINE-LIKE TREATMENTAnother approach to stimulating the immune system is similar to vaccination, except that it is used in people who are already infected with HIV. HRG214 by Virionyx is a genetically engineered group of antibodies to HIV. It is called a "passive immuno-therapeutic pharmaceutical." HRG 214 is in Phase II trials.
A recent study of ALVAC vaccine plus Remune found a delay in viral load rebound when treatment was interrupted.
A recent study showed that a combination of vaccines against HIV and interleukin-2 (IL-2) increased immune responses to HIV and allowed some people to stop antiviral therapy for up to a year.
A novel therapeutic vaccine is DermaVir. It is applied as a skin patch. It is in Phase I/II trials. Another new therapeutic vaccine is VIR201. It is in Phase I/IIa trials. --------------------------------------------------------------------------------
OTHER IMMUNE MODULATORSAVR118 by Advanced Viral Research showed good results against AIDS wasting and anorexia in a Phase I/II study.
HspE7 by StressGen Biotechnologies is being tested in Phase II and Phase III trials for tumors related to human papillomavirus (HPV, see fact sheet 510).
TH9507 by Theratechnolgies is a growth hormone inducer. It is being studied in Phase III to treat visceral fat accumulation in lipodystrophy.
Immunitin (HE2000) by Hollis-Eden Pharmaceuticals is a new drug that works on an infected person's immune system. It is designed to strengthen the "humoral" immune response which is responsible for producing antibodies. HE2000 is being tested in Phase II trials.
IR103 is a combination of Remune by the Immune Response Corporation, which stimulates an immune response to HIV, and Amplivax by Hybridon which uses gene technology to enhance immune responses. IR103 is in a Phase I trial.
MDX010 is an artificial antibody product. Medarex is testing it against HIV in Phase II trials.
Murabutide is under study by Dr. Georges Bahr in France. It uses fragments of bacteria to stimulate the overall immune response. Murabutide is given by injection. Phase I results, reported late in 2001, were promising.
Resveratrol is a chemical found in several plants and the skin of red grapes. It protects plants against pathogens and may have other immune-boosting properties. It is being studied in a Phase I trial in people with HIV.
Reticulose by Advanced Viral Research Corporation is a nucleic acid that stimulates the cell-killing arm of the immune system. It is administered as a subcutaneous (beneath the skin) injection. Early clinical trials showed that patients receiving Reticulose had increases in their CD4 and CD8 cells, weight increases, and fewer opportunistic infections than patients receiving placebo. No toxic side effects have been reported yet. Reticulose is in Phase III trials.
SP-01A by Samaritan Pharmaceuticals normalizes (reduces) levels of cortisol, a stress hormone. A Phase III study is being developed.
Tucaresol by GlaxoSmithKline is an immune stimulator in Phase I trials.
Zenapax (daclizumab or anti-CD25) is being studied by the National Institutes of Health as a way to reduce viral load beyond what ART can achieve!Alittle PRAYER never hurt anyone either eh folks!MAY GODBLESS ALL PHA'S WITH PEACE,LOVE & HAPPINESS!!!WE MUST NOT ALLOW THE HARPER GOV. TO MAKE FUNDING CUTS FOR AIDS SERVICE ORG.BREAK YOUR SILENCE TODAY & START YOUR ATTACK ON HIV-AIDS =BLOGS,VLOGS,WEBPAGES-SITES,or START A DAILY DIARY TELLING OTHERS WAT ITS LIKE TO LIVE WITH HIV-AIDS DAILY!!!!WE CAN DEFEAT STIGMA & DISCRIMINATION IF WE ALL STICK TOGETHER & START AS MANY "FRONT LINES OF ATTACK" AS WE CAN!!!!PLEASE START YER BLOGS-VLOGS-WATEVER IT IS U DECIDE TO DO-JOIN US IN THIS WAR AGAINST HUMANITY-& HELP US STOP THE HARPER GOV CUTS!!!!WE NEED FUNDING INCREASES NOT cuts,especially as more n more peoples R testing poz!!!

Harm Reduction Works Over War on Drugs!!!

Injection-related disease - One third of people with HIV in the United States were infected through injection drug use. Every year, another 8,000 people are newly infected with HIV through sharing contaminated syringes and another 15,000 are infected with Hepatitis C.
These infections are preventable. In communities where access to sterile syringes is supported, transmission of HIV & Hepatitis C in injecting drug users has declined as a proportion of all cases by mode of transmission. Decreases have also been documented among the sex partners and children of injection drug users.
Syringe Exchange programs are highly cost-effective. The lifetime cost of medical care for each new HIV infection is $385,200; the equivalent amount of money spent on syringe exchange programs would prevent at least 30 new HIV infections.
Syringe exchange programs increase access to drug treatment & medical care. In addition to the reduced risks for disease, sterile syringe access programs facilitate greater access to drug treatment. These programs also provide a crucial entry point into medical care, detox and rehabilitation, and mental health treatment.
Nearly 200 syringe exchange programs currently operate in 38 states, Puerto Rico, Washington DC, and Indian Lands. Most operate on a shoestring, surviving on dwindling private donations and severe restrictions of public funding.
The medical and scientific community support syringe exchange. Studies by the Centers for Disease Control and the National Academy of Sciences show that syringe exchange programs are effective. Programs have the support of the medical community, including the American Medical Association, the American Public Health Association and the American Nurses Association
Syringe exchanges get dirty needles off the streets. Research demonstrates that the presence of a syringe exchange program results in fewer used syringes improperly discarded. In Baltimore, after an SEP was implemented, the number of inappropriately discarded syringes decreased by almost 50%. In Portland, the number of discarded syringes decreased by almost two-thirds after the NEP opened. In 1992, Connecticut repealed a law forbidding the sale of syringes without a prescription. As a result, reports show a reduction in needle sharing by 50 percent and a decrease in HIV infections by over 30 percent. In addition, law enforcement officials experienced two-thirds fewer needle stick injuries.

So i urge all PHA's To START YOUR ATTACK ON HIV-AIDS BY BLOGS,VLOGS & VIDEO'S 2!!!

Harm Reduction Works Over War on Drugs!!!

Injection-related disease - One third of people with HIV in the United States were infected through injection drug use. Every year, another 8,000 people are newly infected with HIV through sharing contaminated syringes and another 15,000 are infected with Hepatitis C.
These infections are preventable. In communities where access to sterile syringes is supported, transmission of HIV & Hepatitis C in injecting drug users has declined as a proportion of all cases by mode of transmission. Decreases have also been documented among the sex partners and children of injection drug users.
Syringe Exchange programs are highly cost-effective. The lifetime cost of medical care for each new HIV infection is $385,200; the equivalent amount of money spent on syringe exchange programs would prevent at least 30 new HIV infections.
Syringe exchange programs increase access to drug treatment & medical care. In addition to the reduced risks for disease, sterile syringe access programs facilitate greater access to drug treatment. These programs also provide a crucial entry point into medical care, detox and rehabilitation, and mental health treatment.
Nearly 200 syringe exchange programs currently operate in 38 states, Puerto Rico, Washington DC, and Indian Lands. Most operate on a shoestring, surviving on dwindling private donations and severe restrictions of public funding.
The medical and scientific community support syringe exchange. Studies by the Centers for Disease Control and the National Academy of Sciences show that syringe exchange programs are effective. Programs have the support of the medical community, including the American Medical Association, the American Public Health Association and the American Nurses Association
Syringe exchanges get dirty needles off the streets. Research demonstrates that the presence of a syringe exchange program results in fewer used syringes improperly discarded. In Baltimore, after an SEP was implemented, the number of inappropriately discarded syringes decreased by almost 50%. In Portland, the number of discarded syringes decreased by almost two-thirds after the NEP opened. In 1992, Connecticut repealed a law forbidding the sale of syringes without a prescription. As a result, reports show a reduction in needle sharing by 50 percent and a decrease in HIV infections by over 30 percent. In addition, law enforcement officials experienced two-thirds fewer needle stick injuries.

So i urge all PHA's To START YOUR ATTACK ON HIV-AIDS BY BLOGS,VLOGS & VIDEO'S 2!!!

O.A.N. Leadership Training Program Facing Funding Cuts!!!

Talking about Ontario Aids Network's Leadership training Program-Steps in Right Direction=PHA's Say!!!
I AM REPUBLISHING THIS BECAUSE THE OAN NEEDS YOUR HELP IN THEIR MAILING CAMPAIGNE-GET INVOLVED TODAY!ANY & ALL DONATIONS TO THE ONTARIO AIDS NETWORK or ANY AIDS SERVICE ORG IS GREATLY APRECIATED & NEEDED BADLY!!!THOMAS EGDORF REMAINS TO BE MY HERO-HIS SELFLESSNESS & CONCERN FOR PHA'S in ONT REMAINED UNDEMINISHED-PLEASE HELP TOM TO HELP US HIV+ HUMAN BEINGS LEARN & GROW!JAMES JC GOUGH,SUDBURY ONT CANADA pha hiv-aids EDUCATION & awareness Speaker for Access Aids Sudbury!

O.A.N. Leadership Training Program Facing Funding Cuts!!!

Talking about Ontario Aids Network's Leadership training Program-Steps in Right Direction=PHA's Say!!!
I AM REPUBLISHING THIS BECAUSE THE OAN NEEDS YOUR HELP IN THEIR MAILING CAMPAIGNE-GET INVOLVED TODAY!ANY & ALL DONATIONS TO THE ONTARIO AIDS NETWORK or ANY AIDS SERVICE ORG IS GREATLY APRECIATED & NEEDED BADLY!!!THOMAS EGDORF REMAINS TO BE MY HERO-HIS SELFLESSNESS & CONCERN FOR PHA'S in ONT REMAINED UNDEMINISHED-PLEASE HELP TOM TO HELP US HIV+ HUMAN BEINGS LEARN & GROW!JAMES JC GOUGH,SUDBURY ONT CANADA pha hiv-aids EDUCATION & awareness Speaker for Access Aids Sudbury!